Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R.R.Sudhir 1 DO. DNB. MPH (Johns Hopkins USA) Head of Dept of Preventive.

Similar presentations


Presentation on theme: "Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R.R.Sudhir 1 DO. DNB. MPH (Johns Hopkins USA) Head of Dept of Preventive."— Presentation transcript:

1 Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R.R.Sudhir 1 DO. DNB. MPH (Johns Hopkins USA) Head of Dept of Preventive Ophthalmology Senior Consultant Cornea Services Consultant In-charge of EMR Co-investigators : Sarah Polack 2, Rosa Legod 2, Yasmene Alavi 2, Robert Lindfield 2, Tarun Sharma 1, Hannah Kuper 1 1 Sankara Nethralaya Medical and Vision Research Foundation Chennai, India & 2 International Center For Eye Health (London School of Hygiene & Tropical Medicine)

2 Introdu ction Diabetic retinopathy (DR) can cause blindness, but this can be prevented through early detection and treatment. Diabetic populations in rural communities in India typically have limited access to ophthalmic care. Ensuring regular diabetic ophthalmic examinations for rural populations therefore poses a considerable challenge. Rural Mobile telescreening for DR provides examination services for population who may not otherwise have access to them. Evidence regarding the cost-effectiveness of screening for DR in low income settings is lacking. Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

3 AIM To assess the cost-effectiveness of a telescreening of Diabetic Retinopathy program in rural Southern India and to assess the incremental cost effectiveness ratios associated with different screening intervals. Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

4 Methods We used a Markov model to estimate the cost-utility of a) the current teleophthalmology program which involves one-off screening in comparison to no screening programme, and b)the cost-utility of this program at different screening intervals. Six different screening interval strategies were compared: no screening, once in a life time screening (current approach) and twice in a life time screening, screening every 5 years, 3 years, 2 years and annual screening. The model was based on a hypothetical cohort of 1000 rural diabetes patients aged 40yrs who had not been previously screened for DR. Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

5 Methods To estimate utility values associated with DR, 249 people with diabetes were interviewed using the time-trade off method. Patient and provider costs of screening and treating DR were estimated through interviews with 100 diabetic patients as well as program and hospital managers. The sensitivity and specificity of the DR screening was assessed by comparing it to diagnosis using a gold standard method for 346 diabetes patients. Other model parameters were derived from literature. Incremental cost-utility ratios were calculated from health provider and societal perspective each successive strategy comparing the most to the next least costly (e.g. comparing annual screening to screening every 2years).. Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

6 Markov model parameter estimates assumptions Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

7 StrategyCost $ Incremental costQALY Incremental QALYICER* Health provider perspective No screening Once in a life time ,320 Twice in a life time ,343 Every 5 yrs ,027 Every 3 yrs ,034 Every 2 yrs ,435 Annual ,029 Societal perspective No screening Once in a life time ,692 Twice in a life time ,475 Every 5 yrs ,134 Every 3 yrs ,365 Every 2 yrs ,669 Annual ,677 Incremental cost-effectiveness of different tele-screening intervals- Incremental cost-effectiveness of different tele-screening intervals- comparisons made to next most intensive strategy Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir WHO suggested cost effective range,1-3 times the Indian GDP ($ ).

8 Discussion The Strength of our study : Utility value (0.55) derived from a sample of diabetic patients from the program area. Primary data on costs, effectiveness and diagnostic tool accuracy were collected from the program setting rather than relying on published studies undertaken in other countries. Data on baseline DR prevalence was estimated from a recent population based study conducted in Chennai. Limitation : Our model assumed 100% attendance of the initial cohort at each subsequent DR screening. Although there is evidence that DR screening in rural communities may increase compliance compared to hospital based screening, complete attendance may not be realistic. Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

9 Conclusion Our analysis suggests that a one-off telescreening program for DR is cost-effective compared to no screening in this rural Indian setting from a health provider perspective. Increasing the frequency of screening up to 2 years is also cost-effective, although this is dependent on the administrative costs of establishing and maintaining screening at regular intervals and on achieving sufficient coverage Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R R Sudhir

10 Thank you Acknowledgements Study Grant : Sight Savers International


Download ppt "Cost Utility of Mobile Telescreening of Diabetic Retinopathy in rural south India Dr R.R.Sudhir 1 DO. DNB. MPH (Johns Hopkins USA) Head of Dept of Preventive."

Similar presentations


Ads by Google